-transparent.png){kind=logo}
The reduced form of nicotinamide adenine dinucleotide coenzyme Q reductase (complex I) activity has recently been shown to be deficient in the substantia nigra of patients dying with Parkinson's disease. This biochemical defect is identical to that produced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which also produces parkinsonism in humans. Complex I comprises 25 polypeptides, seven of which are encoded by mitochondrial DNA. Restriction fragment analysis of substantia nigra DNA from six patients with Parkinson's disease did not show any major deletion. In two cases, there were different novel polymorphisms that were not observed in control brain (n = 6) or blood (n = 34) samples.
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
January 1999,
Advances in neurology,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
May 1991,
Neurology,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
January 1994,
Movement disorders : official journal of the Movement Disorder Society,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
March 2017,
Movement disorders : official journal of the Movement Disorder Society,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
December 2020,
Biomedicines,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
April 2017,
Acta neuropathologica communications,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
May 2002,
Journal of neural transmission (Vienna, Austria : 1996),
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
August 1998,
Annals of neurology,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
February 2020,
Aging clinical and experimental research,
A H Schapira, and
I J Holt, and
M Sweeney, and
A E Harding, and
P Jenner, and
C D Marsden
January 1996,
American journal of medical genetics,
